Black Diamond Therapeutics, Inc.
US ˙ NasdaqGS ˙ US09203E1055

Introducere

Această pagină oferă o analiză cuprinzătoare a istoricului cunoscut al tranzacțiilor privilegiate a Samarth Kulkarni. Insiders sunt ofițeri, directori sau investitori importanți într-o companie. Este ilegal ca persoanele din interior să facă tranzacții în companiile lor pe baza unor informații specifice, nepublice. Acest lucru nu înseamnă că este ilegal pentru ei să facă tranzacții în propriile companii. Cu toate acestea, ei trebuie să raporteze toate tranzacțiile către SEC printr-un Formular 4. În ciuda acestor restricții, cercetările academice sugerează că persoanele din interior - în general - tind să depășească piața în propriile companii.

Rentabilitatea medie comercială

Rentabilitatea medie a comerțului este randamentul mediu al tuturor achizițiilor de pe piața deschisă efectuate de persoane din interior în ultimii trei ani. Pentru a calcula acest lucru, examinăm fiecare achiziție neplanificată pe piață deschisă făcută de către insider, excluzând toate tranzacțiile care au fost marcate ca parte a unui plan de tranzacționare 10b5-1. Apoi calculăm performanța medie a acelor tranzacții pe 3, 6 și 12 luni, făcând o medie a fiecărei durate pentru a genera o valoare finală a performanței pentru fiecare tranzacție. În cele din urmă, facem o medie a tuturor valorilor de performanță pentru a calcula o valoare de performanță pentru persoana din interior. Această listă include doar persoane din interior care au efectuat cel puțin trei tranzacții în ultimii doi ani.

Dacă profitabilitatea acestei tranzacții este „N/A”, atunci acesta fie nu a făcut nicio achiziție pe piața deschisă în ultimii trei ani, fie tranzacțiile pe care le-au făcut sunt prea recente pentru a calcula o măsură de performanță fiabilă.

Frecvența actualizării: zilnic

Consultați lista celor mai profitabili comercianți din interior.

Companii cu poziții din interior raportate

Înregistrările SEC indică faptul că Samarth Kulkarni a raportat participații sau tranzacții în următoarele companii:

Securitate Titlu Ultimele participații raportate
US:CRSP / CRISPR Therapeutics AG Chief Executive Officer, Director 255.501
US:RPTX / Repare Therapeutics Inc. Director 49.000
US:BDTX / Black Diamond Therapeutics, Inc. Director 15.000
Cum se interpretează diagramele

Următoarele diagrame arată performanța acțiunilor de valori mobiliare ulterioare fiecărei tranzacții neplanificate pe piață deschisă efectuată de Samarth Kulkarni. Comerțurile neplanificate sunt tranzacții care nu au fost efectuate ca parte a unui plan de tranzacționare 10b5-1. Performanța acțiunilor este reprezentată ca variație procentuală cumulată a prețului acțiunilor. De exemplu, dacă o tranzacție privilegiată a fost efectuată la 1 ianuarie 2019, graficul va afișa modificarea procentuală zilnică a titlului până în prezent. Dacă prețul acțiunilor ar merge de la 10 USD la 15 USD în acest timp, modificarea procentuală cumulativă a prețului acțiunilor ar fi de 50%. O modificare a prețului de la 10 USD la 20 USD ar fi 100%, iar o modificare a prețului de la 10 USD la 5 USD ar fi -50%.

În cele din urmă, încercăm să determinăm cât de strâns se corelează tranzacțiile insider-ului cu randamentele în exces (pozitive sau negative) ale prețului acțiunilor, pentru a vedea dacă insider-ul își programează tranzacțiile pentru a profita de informațiile privilegiate. Luați în considerare situația în care un insider făcea asta. În această situație, ne-am aștepta fie la (a) randamente pozitive după achiziții, fie (b) la profituri negative după vânzare. În cazul punctului (a), graficul CUMPĂRĂRI ar arăta o serie de curbe în pantă ascendentă, indicând randamente pozitive după fiecare tranzacție de cumpărare. În cazul (b), graficul VÂNZARE ar arăta o serie de curbe înclinate în jos, indicând randamente negative după fiecare tranzacție de vânzare.

Cu toate acestea, acest lucru în sine nu este suficient pentru a trage concluzii. Dacă, de exemplu, prețul acțiunilor companiei a fost într-o creștere neciclică de-a lungul multor ani, atunci ne-am aștepta ca toate parcelele post-cumpărare să fie în pantă ascendentă. De asemenea, scăderile non-ciclice de-a lungul multor ani ar avea ca rezultat o pantă descendentă post-tranzacționare. Niciunul dintre aceste grafice nu ar sugera activitate de tranzacționare a informațiilor privilegiate.

Cel mai puternic indicator ar fi o situație în care prețul acțiunilor a fost extrem de ciclic, și au existat atât semnale pozitive în graficul CUMPĂRARE, cât și grafice negative pe graficul VÂNZARE. Această situație ar sugera foarte mult un insider care a programat tranzacțiile în avantajul lor financiar.

Achiziții din interior BDTX / Black Diamond Therapeutics, Inc. - Analiza profitului pe termen scurt

În această secțiune, analizăm profitabilitatea fiecărei achiziții neplanificate, pe piață deschisă, efectuată în BDTX / Black Diamond Therapeutics, Inc.. Această analiză ajută la înțelegerea dacă persoana din interior generează în mod constant profituri anormale și merită urmărită. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .

Următorul tabel prezintă cele mai recente achiziții pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Ticker Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Max
Pret la
Max
Max
Profit ($)
Randament maxim (%)
Nu se cunosc tranzacții neplanificate pe piața deschisă pentru această combinație de informații privilegiate și de securitate

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.

BDTX / Black Diamond Therapeutics, Inc. Insider Trades
Vânzări din interior BDTX / Black Diamond Therapeutics, Inc. - Analiza pierderilor pe termen scurt

În această secțiune, analizăm evitarea pierderilor pe termen scurt a fiecărei vânzări neplanificate, pe piață deschisă, efectuată în BDTX / Black Diamond Therapeutics, Inc.. Un model consistent de evitare a pierderilor poate sugera că viitoarele tranzacții de vânzare pot prezice scăderi ale prețului. Această analiză este pentru un an după fiecare tranzacție, iar rezultatele sunt teoretice .

Următorul tabel arată cele mai recente vânzări pe piața deschisă care nu făceau parte dintr-un plan de tranzacționare automată.

Data tranzacției Ticker Insider Raportat
Acțiuni
Raportat
Preț
Ajustat
Acțiuni
Ajustat
Preț
Baza costurilor Zile pentru
Min
Pret la
Min
Pierdere maximă
Evitat ($)
Pierdere maximă
Evitat (%)
Nu se cunosc tranzacții neplanificate pe piața deschisă pentru această combinație de informații privilegiate și de securitate

Prețul ajustat este prețul ajustat în divizarea. Acțiunile ajustate sunt acțiunile ajustate în funcție de divizarea.

BDTX / Black Diamond Therapeutics, Inc. Insider Trades
Istoricul tranzacțiilor privilegiate

Acest tabel arată lista completă a tranzacțiilor privilegiate efectuate de Samarth Kulkarni, astfel cum a fost dezvăluită Comisiei pentru Bursa de Valori Valori (SEC).

Data fișierului Tran Data Formă Ticker Securitate Cod 10b5-1 Acțiuni Acțiuni rămase La sută
Schimbare
Acțiune
Preț
Tran
Valoare
Rămas
Valoare
2026-03-24 2026-03-23 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -10.020 255.501 -3,77 46,78 -468.736 11.952.337
2026-03-24 2026-03-20 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 19.687 265.521 8,01
2026-03-17 2026-03-16 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -10.349 245.834 -4,04 48,26 -499.443 11.863.949
2026-03-17 2026-03-14 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 20.625 256.183 8,76
2026-03-12 2026-03-11 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -9.798 235.558 -3,99 52,80 -517.334 12.437.462
2026-03-12 2026-03-10 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 19.250 245.356 8,51
2026-02-20 2026-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -6.967 226.106 -2,99 52,58 -366.325 11.888.653
2026-02-20 2026-02-18 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 13.250 233.073 6,03
2026-01-22 2026-01-22 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -60.000 134.201 -30,90 60,23 -3.613.800 8.082.926
2026-01-22 2026-01-20 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -8.567 194.201 -4,23 52,10 -446.341 10.117.872
2026-01-22 2026-01-20 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -21.433 202.768 -9,56 51,61 -1.106.157 10.464.856
2025-12-22 2025-12-18 4 CRSP CRISPR Therapeutics AG
Common Shares
G - Gift -30.000 224.201 -11,80
2025-10-20 2025-10-17 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -50.895 254.201 -16,68 67,91 -3.456.279 17.262.790
2025-10-20 2025-10-16 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 100.000 305.096 48,76
2025-10-15 2025-10-14 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -4.242 205.096 -2,03 66,60 -282.517 13.659.394
2025-10-15 2025-10-13 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 8.334 209.338 4,15
2025-09-19 2025-09-17 4 CRSP CRISPR Therapeutics AG
Common Shares
G - Gift -6.000 201.004 -2,90
2025-08-19 2025-08-18 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -13.081 207.004 -5,94 58,15 -760.660 12.037.283
2025-08-19 2025-08-16 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 25.000 220.085 12,81
2025-03-24 2025-03-21 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -10.031 195.085 -4,89 41,23 -413.578 8.043.355
2025-03-24 2025-03-20 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 19.688 205.116 10,62
2025-03-12 2025-03-12 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -4.462 185.428 -2,35 43,32 -193.294 8.032.741
2025-03-12 2025-03-11 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 9.000 189.890 4,98
2025-03-12 2025-03-11 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -9.973 180.890 -5,23 42,42 -423.055 7.673.354
2025-03-12 2025-03-10 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 19.250 190.863 11,22
2025-02-21 2025-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -18.360 171.613 -9,66 55,20 -1.013.564 9.473.896
2025-02-19 2025-02-19 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -6.928 189.973 -3,52 52,80 -365.798 10.030.574
2025-02-19 2025-02-18 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -11.640 196.901 -5,58 55,05 -640.782 10.839.400
2025-02-19 2025-02-18 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 13.250 208.541 6,78
2024-12-27 2024-12-24 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 13.751 195.291 7,57 16,21 222.904 3.165.667
2024-12-04 2024-12-02 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -15.000 181.540 -7,63 55,10 -826.564 10.003.635
2024-11-13 2024-11-11 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -6.879 196.540 -3,38 56,27 -387.081 11.059.306
2024-11-13 2024-11-11 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -23.121 203.419 -10,21 55,43 -1.281.597 11.275.515
2024-10-15 2024-10-14 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -4.293 226.540 -1,86 46,28 -198.680 10.484.271
2024-10-15 2024-10-13 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 8.333 230.833 3,75
2024-08-12 2024-08-08 4 CRSP CRISPR Therapeutics AG
Common Shares
G - Gift -100.000 222.500 -31,01
2024-04-17 2024-04-15 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -1.204 208.122 -0,58 60,40 -72.722 12.570.631
2024-04-17 2024-04-15 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -18.378 209.326 -8,07 59,88 -1.100.510 12.534.839
2024-04-17 2024-04-15 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 19.582 227.704 9,41 19,12 374.408 4.353.700
2024-03-18 2024-03-15 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -9.387 208.122 -4,32 73,06 -685.818 15.205.477
2024-03-18 2024-03-15 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -10.613 217.509 -4,65 71,97 -763.810 15.653.970
2024-03-18 2024-03-15 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 20.000 228.122 9,61 19,12 382.400 4.361.693
2024-03-12 2024-03-12 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -4.583 208.122 -2,15 74,44 -341.159 15.492.602
2024-03-12 2024-03-11 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 9.000 212.705 4,42
2024-03-12 2024-03-11 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -9.802 203.705 -4,59 78,26 -767.105 15.941.953
2024-03-12 2024-03-10 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 19.250 213.507 9,91
2024-02-21 2024-02-20 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale -6.370 194.257 -3,18 79,67 -507.498 15.476.455
2024-02-21 2024-02-18 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 13.250 200.627 7,07
2024-02-16 2024-02-15 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -1.100 187.377 -0,58 81,66 -89.831 15.302.049
2024-02-16 2024-02-15 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -5.951 188.477 -3,06 81,04 -482.257 15.273.780
2024-02-16 2024-02-15 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -12.949 194.428 -6,24 79,94 -1.035.090 15.541.777
2024-02-16 2024-02-15 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 20.000 207.377 10,67 19,12 382.400 3.965.048
2024-01-31 2024-01-29 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -700 187.377 -0,37 61,10 -42.770 11.448.697
2024-01-31 2024-01-29 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -49.300 188.077 -20,77 60,50 -2.982.803 11.379.242
2024-01-31 2024-01-29 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 50.000 237.377 26,68 19,12 956.000 4.538.648
2024-01-18 2024-01-16 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -20.000 187.377 -9,64 62,50 -1.250.058 11.711.606
2024-01-18 2024-01-16 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 20.000 207.377 10,67 19,12 382.400 3.965.048
2023-06-01 2023-05-30 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.400 387.377 -0,62 66,83 -160.401 25.889.877
2023-06-01 2023-05-30 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -9.300 389.777 -2,33 65,63 -610.359 25.581.065
2023-06-01 2023-05-30 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -5.999 399.077 -1,48 64,46 -386.682 25.723.586
2023-06-01 2023-05-30 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -7.301 405.076 -1,77 63,61 -464.452 25.768.869
2023-06-01 2023-05-30 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 25.000 412.377 6,45 19,12 478.000 7.884.648
2023-04-27 2023-04-25 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -4.393 387.377 -1,12 51,45 -226.021 19.930.663
2023-04-27 2023-04-25 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -20.607 391.770 -5,00 50,50 -1.040.616 19.783.680
2023-04-27 2023-04-25 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 25.000 412.377 6,45 19,12 478.000 7.884.648
2023-03-31 2023-03-29 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -5.281 387.377 -1,34 44,78 -236.506 17.348.447
2023-03-31 2023-03-29 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -19.719 392.658 -4,78 44,37 -874.997 17.423.531
2023-03-31 2023-03-29 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 25.000 412.377 6,45 19,12 478.000 7.884.648
2023-03-14 2023-03-13 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -4.086 387.377 -1,04 43,22 -176.597 16.742.434
2023-03-14 2023-03-13 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -5.358 382.463 -1,38 43,22 -231.573 16.530.051
2023-03-14 2023-03-11 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 9.000 391.463 2,35
2023-03-14 2023-03-10 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 11.833 387.821 3,15
2023-03-01 2023-02-27 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -1.100 375.988 -0,29 49,20 -54.118 18.498.083
2023-03-01 2023-02-27 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -13.720 377.088 -3,51 48,57 -666.415 18.316.107
2023-03-01 2023-02-27 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -10.180 390.808 -2,54 47,71 -485.710 18.646.309
2023-03-01 2023-02-27 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 25.000 400.988 6,65 19,12 478.000 7.666.891
2023-02-22 2023-02-21 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -6.373 375.988 -1,67 48,26 -307.561 18.145.181
2023-02-22 2023-02-18 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 13.250 382.361 3,59
2023-01-31 2023-01-27 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -23.200 369.111 -5,91 51,54 -1.195.712 19.023.723
2023-01-31 2023-01-27 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -1.800 392.311 -0,46 50,60 -91.086 19.852.192
2023-01-31 2023-01-27 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 25.000 394.111 6,77 19,12 478.000 7.535.402
2022-12-30 2022-12-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -4.634 369.111 -1,24 41,45 -192.101 15.301.349
2022-12-30 2022-12-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -20.366 373.745 -5,17 40,81 -831.189 15.253.505
2022-12-30 2022-12-28 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 25.000 394.111 6,77 19,12 478.000 7.535.402
2022-12-08 2022-12-06 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 58.233 369.111 18,73 1,81 105.402 668.091
2022-12-06 2022-12-05 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -19.401 310.878 -5,87 52,26 -1.013.896 16.246.484
2022-12-06 2022-12-03 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 40.000 330.279 13,78
2022-11-30 2022-11-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.310 290.279 -0,79 55,40 -127.983 16.082.589
2022-11-30 2022-11-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -5.572 292.589 -1,87 54,85 -305.598 16.047.131
2022-11-30 2022-11-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -17.118 298.161 -5,43 53,58 -917.246 15.976.570
2022-11-30 2022-11-28 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 25.000 315.279 8,61 19,12 478.000 6.028.134
2022-10-28 2022-10-26 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -7.188 290.279 -2,42 55,69 -400.333 16.166.973
2022-10-28 2022-10-26 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -11.312 297.467 -3,66 54,97 -621.774 16.350.541
2022-10-28 2022-10-26 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -4.000 308.779 -1,28 54,06 -216.254 16.693.673
2022-10-28 2022-10-26 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.500 312.779 -0,79 52,73 -131.830 16.493.462
2022-10-28 2022-10-26 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 5.418 315.279 1,75 19,12 103.592 6.028.134
2022-10-28 2022-10-26 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 19.582 309.861 6,75 16,21 317.424 5.022.847
2022-09-30 2022-09-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -1.800 290.279 -0,62 64,97 -116.946 18.859.427
2022-09-30 2022-09-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -23.200 292.079 -7,36 64,58 -1.498.214 18.861.936
2022-09-30 2022-09-28 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 25.000 315.279 8,61 16,21 405.250 5.110.673
2022-08-31 2022-08-29 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -163 290.279 -0,06 67,64 -11.025 19.634.472
2022-08-31 2022-08-29 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -20.764 290.442 -6,67 66,98 -1.390.669 19.452.353
2022-08-31 2022-08-29 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -4.073 311.206 -1,29 66,14 -269.390 20.583.320
2022-08-31 2022-08-29 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 25.000 315.279 8,61 16,21 405.250 5.110.673
2022-07-29 2022-07-27 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -600 290.279 -0,21 77,97 -46.783 22.633.547
2022-07-29 2022-07-27 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -3.308 290.879 -1,12 76,29 -252.382 22.192.439
2022-07-29 2022-07-27 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -12.759 294.187 -4,16 75,73 -966.265 22.279.370
2022-07-29 2022-07-27 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -700 306.946 -0,23 77,79 -54.455 23.878.219
2022-07-29 2022-07-27 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -700 307.646 -0,23 76,37 -53.461 23.495.848
2022-07-29 2022-07-27 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -6.933 308.346 -2,20 75,64 -524.402 23.322.829
2022-07-29 2022-07-27 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 16.667 315.279 5,58 16,21 270.172 5.110.673
2022-07-29 2022-07-27 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 8.333 298.612 2,87 12,57 104.746 3.753.553
2022-07-01 2022-06-29 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -4.740 290.279 -1,61 62,32 -295.407 18.090.826
2022-07-01 2022-06-29 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -20.260 295.019 -6,43 61,42 -1.244.454 18.121.306
2022-07-01 2022-06-29 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 25.000 315.279 8,61 12,57 314.250 3.963.057
2022-05-16 2022-05-13 4 RPTX Repare Therapeutics Inc.
Stock Option (right to buy)
A - Award 49.000 49.000
2022-03-14 2022-03-14 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -4.153 290.279 -1,41 61,08 -253.665 17.730.241
2022-03-14 2022-03-11 4 CRSP CRISPR Therapeutics AG
Restricted Stock Units
M - Exercise -9.000 27.000 -25,00
2022-03-14 2022-03-11 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 9.000 294.432 3,15
2022-03-14 2022-03-11 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -5.487 285.432 -1,89 62,56 -343.267 17.856.626
2022-03-14 2022-03-10 4 CRSP CRISPR Therapeutics AG
Restricted Stock Units
M - Exercise -11.834 11.833 -50,00
2022-03-14 2022-03-10 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 11.834 290.919 4,24
2022-02-22 2022-02-18 4 CRSP CRISPR Therapeutics AG
Restricted Stock Units
A - Award 53.000 53.000
2022-02-22 2022-02-18 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 115.000 115.000
2021-12-22 2021-12-20 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
M - Exercise -17.750 58.233 -23,36
2021-12-22 2021-12-20 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 17.750 279.085 6,79 1,81 32.128 505.144
2021-12-07 2021-12-06 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -37.818 261.335 -12,64 69,17 -2.615.871 18.076.542
2021-12-07 2021-12-03 4 CRSP CRISPR Therapeutics AG
Restricted Stock Units
M - Exercise 80.000 40.000 -200,00
2021-12-07 2021-12-03 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 80.000 299.153 36,50
2021-12-03 2021-12-01 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -779 219.153 -0,35 75,10 -58.503 16.458.390
2021-10-18 2021-10-15 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
M - Exercise -33.000 75.983 -30,28
2021-10-18 2021-10-15 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 43.000 43.000
2021-10-18 2021-10-15 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 33.000 219.932 17,65 1,81 59.730 398.077
2021-09-03 2021-09-01 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -787 186.932 -0,42 124,83 -98.241 23.334.722
2021-08-06 2021-08-05 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
M - Exercise -28.500 33.333 -46,09
2021-08-06 2021-08-05 4 CRSP CRISPR Therapeutics AG
Common Stock
S - Sale X -2.482 187.719 -1,30 130,51 -323.926 24.499.207
2021-08-06 2021-08-05 4 CRSP CRISPR Therapeutics AG
Common Stock
S - Sale X -6.819 190.201 -3,46 129,82 -885.243 24.691.894
2021-08-06 2021-08-05 4 CRSP CRISPR Therapeutics AG
Common Stock
S - Sale X -13.499 197.020 -6,41 128,85 -1.739.346 25.386.027
2021-08-06 2021-08-05 4 CRSP CRISPR Therapeutics AG
Common Stock
S - Sale X -4.700 210.519 -2,18 127,82 -600.754 26.908.539
2021-08-06 2021-08-05 4 CRSP CRISPR Therapeutics AG
Common Stock
S - Sale X -1.000 215.219 -0,46 126,67 -126.670 27.261.791
2021-08-06 2021-08-05 4 CRSP CRISPR Therapeutics AG
Common Stock
M - Exercise 28.500 216.219 15,18 12,57 358.245 2.717.873
2021-08-06 2021-08-04 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
M - Exercise -1.500 61.833 -2,37
2021-08-06 2021-08-04 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -1.500 187.719 -0,79 125,02 -187.530 23.468.629
2021-08-06 2021-08-04 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 1.500 189.219 0,80 12,57 18.855 2.378.483
2021-06-22 2021-06-18 4 BDTX Black Diamond Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 15.000 15.000
2021-06-17 2021-06-15 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
M - Exercise -30.000 63.333 -32,14
2021-06-17 2021-06-15 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -3.488 187.719 -1,82 127,51 -444.755 23.936.050
2021-06-17 2021-06-15 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -16.129 191.207 -7,78 126,86 -2.046.125 24.256.520
2021-06-17 2021-06-15 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -10.383 207.336 -4,77 125,39 -1.301.924 25.997.861
2021-06-17 2021-06-15 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 30.000 217.719 15,98 12,57 377.100 2.736.728
2021-06-03 2021-06-01 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -779 187.719 -0,41 115,80 -90.208 21.737.860
2021-05-14 2021-05-13 4 RPTX Repare Therapeutics Inc.
Stock Option (right to buy)
A - Award 21.000 21.000
2021-04-23 2021-04-20 4 BDTX Black Diamond Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 14.921 14.921
2021-03-12 2021-03-11 4 CRSP CRISPR Therapeutics AG
Restricted Stock Units
A - Award 36.000 36.000
2021-03-12 2021-03-11 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 100.000 100.000
2021-03-12 2021-03-10 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -5.526 188.498 -2,85 124,15 -686.053 23.402.027
2021-03-12 2021-03-10 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 11.833 194.024 6,49
2021-03-03 2021-03-01 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -798 182.191 -0,44 130,25 -103.940 23.730.378
2021-01-20 2021-01-15 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
M - Exercise -20.000 108.983 -15,51
2021-01-20 2021-01-15 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -1.304 182.989 -0,71 217,44 -283.542 39.789.128
2021-01-20 2021-01-15 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -1.708 184.293 -0,92 216,50 -369.782 39.899.434
2021-01-20 2021-01-15 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -1.700 186.001 -0,91 214,68 -364.956 39.930.695
2021-01-20 2021-01-15 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -5.623 187.701 -2,91 213,71 -1.201.691 40.113.581
2021-01-20 2021-01-15 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -6.525 193.324 -3,26 212,75 -1.388.194 41.129.681
2021-01-20 2021-01-15 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -3.140 199.849 -1,55 211,83 -665.146 42.334.014
2021-01-20 2021-01-15 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 20.000 202.989 10,93 1,81 36.200 367.410
2020-12-30 2020-12-29 4 CRSP CRISPR Therapeutics AG
Stock Option (right to buy)
M - Exercise -13.800 128.983 -9,67
2020-12-30 2020-12-29 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 13.800 182.989 8,16 1,81 24.978 331.210
2020-12-11 2020-12-10 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
M - Exercise -20.000 142.783 -12,29
2020-12-11 2020-12-10 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -600 169.189 -0,35 144,97 -86.982 24.527.329
2020-12-11 2020-12-10 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.100 169.789 -1,22 143,71 -301.791 24.400.377
2020-12-11 2020-12-10 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -6.766 171.889 -3,79 142,75 -965.846 24.537.155
2020-12-11 2020-12-10 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -5.034 178.655 -2,74 141,98 -714.727 25.365.437
2020-12-11 2020-12-10 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -5.500 183.689 -2,91 141,17 -776.435 25.931.376
2020-12-11 2020-12-10 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 20.000 189.189 11,82 1,81 36.200 342.432
2020-12-03 2020-12-01 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -779 169.189 -0,46 129,58 -100.943 21.923.511
2020-10-06 2020-10-05 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 47.333 47.333
2020-09-03 2020-09-02 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -779 169.968 -0,46 94,15 -73.343 16.002.487
2020-06-03 2020-06-02 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -779 170.747 -0,45 66,26 -51.617 11.313.696
2020-06-03 2020-06-01 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
M - Exercise -17.275 162.783 -9,59
2020-06-03 2020-06-01 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -5.575 171.526 -3,15 65,26 -363.824 11.193.787
2020-06-03 2020-06-01 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -9.300 177.101 -4,99 64,61 -600.873 11.442.496
2020-06-03 2020-06-01 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.400 186.401 -1,27 63,57 -152.568 11.849.512
2020-06-03 2020-06-01 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 17.275 188.801 10,07 1,81 31.268 341.730
2020-05-21 2020-05-20 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
M - Exercise -10.693 180.058 -5,61
2020-05-21 2020-05-20 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -10.693 171.526 -5,87 65,28 -698.039 11.197.217
2020-05-21 2020-05-20 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 10.693 182.219 6,23 1,81 19.354 329.816
2020-05-21 2020-05-19 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
M - Exercise -4.307 190.751 -2,21
2020-05-21 2020-05-19 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -4.307 171.526 -2,45 65,16 -280.644 11.176.634
2020-05-21 2020-05-19 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 4.307 175.833 2,51 1,81 7.796 318.258
2020-03-12 2020-03-10 4 CRSP CRISPR Therapeutics AG
Restricted Stock Units
A - Award 35.500 35.500
2020-03-12 2020-03-10 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 142.000 142.000
2020-03-04 2020-03-02 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -794 171.526 -0,46 52,74 -41.876 9.046.281
2019-12-18 2019-12-16 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
M - Exercise -8.000 195.058 -3,94
2019-12-18 2019-12-16 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 8.000 172.320 4,87 1,81 14.480 311.899
2019-12-05 2019-12-03 4 CRSP CRISPR Therapeutics AG
Restricted Stock Units
A - Award 120.000 120.000
2019-12-02 2019-12-01 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -741 164.320 -0,45 71,65 -53.093 11.773.528
2019-09-03 2019-09-01 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -740 165.061 -0,45 46,21 -34.195 7.627.469
2019-06-19 2019-06-17 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
M - Exercise -20.000 203.058 -8,97
2019-06-19 2019-06-17 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -20.000 165.801 -10,76 46,00 -920.000 7.626.846
2019-06-19 2019-06-17 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 20.000 185.801 12,06 1,81 36.200 336.300
2019-06-04 2019-06-01 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -741 165.801 -0,44 35,57 -26.357 5.897.542
2019-05-01 2019-04-29 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
M - Exercise -20.000 223.058 -8,23
2019-05-01 2019-04-29 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -20.000 166.542 -10,72 42,03 -840.600 6.999.760
2019-05-01 2019-04-29 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 20.000 186.542 12,01 1,81 36.200 337.641
2019-03-07 2019-03-05 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 250.000 250.000
2019-03-05 2019-03-01 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -748 166.542 -0,45 39,97 -29.898 6.656.684
2018-12-11 2018-12-07 4 CRSP CRISPR Therapeutics AG
Stock Options (Right to Buy)
M - Exercise -21.500 243.058 -8,13
2018-12-11 2018-12-07 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 21.500 167.290 14,75 1,81 38.915 302.795
2018-12-03 2018-12-01 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -741 145.790 -0,51 38,33 -28.403 5.588.131
2018-09-04 2018-09-01 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -741 146.531 -0,50 56,67 -41.992 8.303.912
2018-06-15 2018-06-15 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 109.000 109.000
2018-06-05 2018-06-04 4 CRSP CRISPR Therapeutics AG
Common Shares
F - Taxes -741 147.819 -0,50 67,13 -49.743 9.923.089
2018-06-05 2018-06-01 4 CRSP CRISPR Therapeutics AG
Employee Stock Option (right to buy)
M - Exercise -15.000 264.558 -5,37
2018-06-05 2018-06-01 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -10.400 148.560 -6,54 70,28 -730.912 10.440.797
2018-06-05 2018-06-01 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -4.600 158.960 -2,81 67,28 -309.488 10.694.829
2018-06-05 2018-06-01 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 15.000 163.560 10,10 1,81 27.150 296.044
2018-04-18 2018-04-16 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award -75.000 150.000 -33,33
2018-03-14 2017-12-01 4 CRSP CRISPR Therapeutics AG
Stock option (right to buy)
A - Award -75.000 75.000 -50,00
2018-03-09 2018-03-07 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 136.000 136.000
2017-12-26 2017-12-21 4 CRSP CRISPR Therapeutics AG
Employee Stock Option (right to buy)
M - Exercise -15.000 279.558 -5,09
2017-12-26 2017-12-21 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 15.000 148.560 11,23 1,81 27.150 268.894
2017-12-05 2017-12-01 4 CRSP CRISPR Therapeutics AG
Stock Option (Right to Buy)
A - Award 260.000 260.000
2017-12-05 2017-12-01 4 CRSP CRISPR Therapeutics AG
Restricted Stock Units
A - Award 26.667 133.560 24,95 19,12 509.873 2.553.667
2017-08-30 2017-08-30 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -4.000 106.893 -3,61 20,00 -80.000 2.137.860
2017-08-30 2017-08-28 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -23.154 110.893 -17,27 20,09 -465.162 2.227.829
2017-05-05 2017-05-03 4 CRSP CRISPR Therapeutics AG
Stock Options (Right to Buy)
A - Award 100.000 100.000
2017-04-28 2017-04-27 4 CRSP CRISPR Therapeutics AG
Stock Options (Right to Buy)
M - Exercise -2.206 294.558 -0,74
2017-04-28 2017-04-27 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.206 134.047 -1,62 16,78 -37.023 2.249.684
2017-04-28 2017-04-27 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 2.206 136.253 1,65 1,81 3.993 246.618
2017-04-28 2017-04-26 4 CRSP CRISPR Therapeutics AG
Stock Options (Right to Buy)
M - Exercise -3.275 296.764 -1,09
2017-04-28 2017-04-26 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -3.275 134.047 -2,38 16,74 -54.816 2.243.652
2017-04-28 2017-04-26 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 3.275 137.322 2,44 1,81 5.928 248.553
2017-04-25 2017-04-25 4 CRSP CRISPR Therapeutics AG
Stock Options (Right to Buy)
M - Exercise -5.115 300.039 -1,68
2017-04-25 2017-04-25 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -5.115 134.047 -3,68 16,87 -86.290 2.261.373
2017-04-25 2017-04-25 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 5.115 139.162 3,82 1,81 9.258 251.883
2017-04-25 2017-04-24 4 CRSP CRISPR Therapeutics AG
Stock Options (Right to Buy)
M - Exercise -3.500 305.154 -1,13
2017-04-25 2017-04-24 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -3.500 134.047 -2,54 16,46 -57.619 2.206.776
2017-04-25 2017-04-24 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 3.500 137.547 2,61 1,81 6.335 248.960
2017-04-25 2017-04-21 4 CRSP CRISPR Therapeutics AG
Stock Options (Right to Buy)
M - Exercise -3.000 308.654 -0,96
2017-04-25 2017-04-21 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -3.000 134.047 -2,19 17,01 -51.033 2.280.260
2017-04-25 2017-04-21 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 3.000 137.047 2,24 1,81 5.430 248.055
2017-04-21 2017-04-20 4 CRSP CRISPR Therapeutics AG
Stock Options (Right to Buy)
M - Exercise -2.800 311.654 -0,89
2017-04-21 2017-04-20 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.800 134.047 -2,05 17,36 -48.621 2.327.686
2017-04-21 2017-04-20 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 2.800 136.847 2,09 1,81 5.068 247.693
2017-04-21 2017-04-19 4 CRSP CRISPR Therapeutics AG
Stock Options (Right to Buy)
M - Exercise -7.258 314.454 -2,26
2017-04-21 2017-04-19 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -2.449 134.047 -1,79 18,54 -45.393 2.484.601
2017-04-21 2017-04-19 4 CRSP CRISPR Therapeutics AG
Common Shares
S - Sale X -4.809 136.496 -3,40 17,54 -84.361 2.394.467
2017-04-21 2017-04-19 4 CRSP CRISPR Therapeutics AG
Common Shares
M - Exercise 7.258 141.305 5,41 1,81 13.137 255.762
2016-10-18 3 CRSP CRISPR Therapeutics AG
Common Shares
268.094
2016-10-18 3 CRSP CRISPR Therapeutics AG
Common Shares
268.094
P
Piața deschisă sau achiziția privată de titluri nederivate sau derivate
S
Piața deschisă sau vânzarea privată a titlurilor de valoare nederivate sau derivate
A
Acordarea, atribuirea sau alte achiziții de valori mobiliare de la companie (cum ar fi o opțiune)
C
Conversia derivatei
D
Vânzarea sau transferul de valori mobiliare înapoi către companie
F
Plata prețului de exercițiu sau a obligației fiscale folosind o parte din titlurile de valoare primite de la companie
G
Donarea de valori mobiliare de către sau către persoane din interior
K
Swap-uri de acțiuni și tranzacții similare de acoperire împotriva riscurilor
M
Exercitarea sau conversia titlurilor derivate primite de la companie (cum ar fi o opțiune)
V
O tranzacție raportată voluntar pe Formularul 4
J
Altele (însoțite de o notă de subsol care descrie tranzacția)